The U.S. has recorded its first fatal case of H5N1 bird flu, in a person from Louisiana who contracted the virus from ...

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...

Rather than relying on those testing the devices to judge skin tones, the draft guidance suggests manufacturers should either ...

The annual J.P. Morgan Healthcare Conference starts next week, and the circumstances surrounding the event are difficult to ...

Today's health news includes potential cuts to Medicaid under the Trump administration and the five-year anniversary of Covid ...

A new government study reviewing past research on the safety of fluoride for children found a slight decrease in IQ scores ...

If the new administration slashes federal Medicaid spending, millions of people with disabilities would be cut off from ...

Five years after the start of Covid, we appear to be trying to teach ourselves the lessons of the pandemic the hard way.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A new federal transparency rule requires some developers to disclose details about how their health AI tools were developed and tested.

Novo Nordisk filed another petition with the FDA seeking to block compounding pharmacies from making versions of one of its GLP-1 drugs ...